Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04391166 · ClinicalTrials.gov registry record
Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 108
- Enrollment target
NCT04391166 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 108 participants.
The verdict
NCT04391166 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social distancing. As part of remote examinations, patients may be expected to perform home eye testing for visual acuity and the use of various home visual acuity charts have been proposed to provide clinicians with this vital data. However, the use of home visual acuity exams has not been validated in our patient population. This project aims to determine the efficacy and validity of measuring visual acuity at home with a printed-out ETDRS chart.
Interventions
- OTHER Non invasive visual acuity testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2020-05-20 |
| Est. Completion | 2020-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04391166
The ClinicalTrials.gov registry entry for NCT04391166 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non invasive visual acuity testing is the first listed.
NCT04391166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04391166 about?
NCT04391166 is a clinical study titled "Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic". Prompted by the current COVID-19 pandemic, the American Academy of Ophthalmology has recommended the use of telemedicine to continue ophthalmic care while maintaining patient and provider social distancing. As part of remote examinations, patients may be expected to perform home eye testing for visu...
What is the current status of trial NCT04391166?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2020-05-20. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT04391166?
The interventions under investigation include: Non invasive visual acuity testing (OTHER).
Who is sponsoring clinical trial NCT04391166?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.